Immune Checkpoint Receptor Expression Profiles of MAIT Cells in Moderate and Severe COVID ‐19
Scandinavian Journal of Immunology · 2025
DOI: 10.1111/sji.70008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Matyas Meggyes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Immunology, Medical School, University of Pecs, Pecs, Hungary. Hauptthemen laut MEDLINE: COVID-19, Mucosal-Associated Invariant T Cells, SARS-CoV-2, Immune Checkpoint Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Pecs Medical School Research Grant.
Abstract (Originalsprache)
MAIT cells are one of the largest unconventional T cell populations and, recruited to the site of infection, play both protective and pathogenic roles during pulmonary viral infections. MAIT cell activation patterns change significantly during COVID‐19, with a notable decrease in their frequency in peripheral blood of severe cases. In the present study, we aimed to investigate the expression profiles of various immune checkpoint pathways on MAIT, MAIT‐like and non‐MAIT cells in moderate and severe COVID‐19 patients undergoing cytokine storm. Despite numerous studies comparing MAIT cell characteristics based on COVID‐19 disease severity, none have delved into the critical differences in MAIT cell immune checkpoint profiles between moderate and severe COVID‐19 patients, all experiencing a cytokine storm. Flow cytometry was used to analyse peripheral blood mononuclear cells from a cohort of 35 patients, comprising 18 moderate and 17 severe cases, alongside 14 healthy controls. Our investigation specifically focuses on severe COVID‐19 presentations, revealing a marked deletion of MAIT cells. Further exploration into the regulatory dynamics of MAIT cell functionality reveals shifts in the expression profiles of critical immune checkpoint receptors, notably PD‐1 and CD226. In severe COVID‐19 patients, MAIT cells showed a significant decrease in the expression of CD226, whereas MAIT‐like and non‐MAIT cells demonstrated a significant increase in the expression of PD‐1 compared to healthy individuals. The expression of the TIGIT receptor remained unaltered across all investigated groups. Our findings contribute to the existing knowledge by elucidating the changes in MAIT cell subpopulations and their potential role in COVID‐19 disease severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology and Immunology, Medical School, University of Pecs, Pecs, Hungary.
- Janos Szentagothai Research Centre, Pecs, Hungary.
- Institute of Geobotany/Plant Ecology, Martin-Luther-University, Halle (Saale), Germany.
- Department of Anesthesiology and Intensive Therapy, Medical School, University of Pecs, Pecs, Hungary.
- 1st Department of Medicine, Division of Infectious Diseases, Medical School, University of Pecs, Pecs, Hungary.
- Department of Laboratory Medicine, Medical School, University of Pecs, Pecs, Hungary.
ORCID-Profile: Laszlo Szereday
Förderung
- University of Pecs Medical School Research Grant
Zitieren
APA
Meggyes, M., Nagy, D. U., Toth, I., Feik, T., Polgar, B., Deen, I. S. A., Sipos, D., Szereday, L., & Peterfalvi, A. (2025). Immune Checkpoint Receptor Expression Profiles of MAIT Cells in Moderate and Severe COVID ‐19. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70008
Vancouver
Meggyes M, Nagy DU, Toth I, Feik T, Polgar B, Deen ISA, et al. Immune Checkpoint Receptor Expression Profiles of MAIT Cells in Moderate and Severe COVID ‐19. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70008
BibTeX
@article{Meggyes2025,
author = {Meggyes, Matyas and Nagy, David U and Toth, Ildiko and Feik, Timoteus and Polgar, Beata and Deen, Iyad Saad Al and Sipos, David and Szereday, Laszlo and Peterfalvi, Agnes},
title = {Immune Checkpoint Receptor Expression Profiles of MAIT Cells in Moderate and Severe COVID ‐19},
journal = {Scandinavian Journal of Immunology},
year = {2025},
doi = {10.1111/sji.70008}
}
EUVIMED